BioWorld

Nov. 2, 2009

View Archived Issues

IPO Window - Are You Kidding? M&A Coming to the Rescue Now

Biotech Rebound May Create More Questions than Answers

Money Raised By Biotech in 2009

Week in Review

Word on the Street

Collaborations Between Biotechnology Companies And Government/Nonprofit Institutions: May 1 - Oct. 29, 2009

Searching for a Clinical Path Through the Fog of Statistics

"Biostatistics is an art, and like any art, it is open to interpretation," said David Miller, CEO of independent research firm Biotech Stock Research LLC. Read More

Money Raised Year to Date

Stock Gainers and Losers For The Week

BioWorld Stock Report For Public Biotechnology Companies

Today's news in brief

BioWorld

BioWorld briefs for July 17, 2026.

Celia trial: data strong, analysts skeptical

BioWorld

Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...

News in brief

BioWorld Asia

BioWorld Asia briefs for July 14, 2026

Elderly hands holding broken brain structure

Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability

BioWorld Science

Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...

ALN-5288 lowers tau levels in preclinical models

BioWorld Science

Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....